Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
01 1Biophore India Pharmaceuticals Pvt Ltd
02 12care4
03 1Abboxia Ab
04 2Alkem Laboratories
05 1Altan Pharma
06 1Annora Pharma
07 1Aristo Pharma GmbH
08 1Avet Pharmaceuticals
09 2Azurity Pharma
10 1BB FARMA Srl
11 1BENEDETTI SpA
12 10Bayer AG
13 1Bionpharma
14 1Brooks laboratories Limited
15 5Central Procurement & Supplies Unit
16 1Cherubino Limited
17 1DOC Generici
18 1EG SpA
19 2Ebb Medical
20 2Future Health Pharma Gmbh
21 1GERMED PLIVA PHARMA SpA
22 1Ha Noi CPC1 Pharmaceutical JSC
23 2Italfarmaco S.p.A
24 1LABORATOIRE X.0
25 2Laboratoire X.O
26 2Laboratoire X.O.
27 2MEDOCHEMIE LTD
28 1Madras Pharmaceuticals
29 1Medartuum
30 1Neuraxpharm
31 7ORIFARM GROUP AS
32 1Omnia L?kemedel Ab
33 1PROGRAMMI SANIT.INTEGRATI Srl
34 2Paranova Group AS
35 2Reyoung pharmaceutical
36 1SINTACTICA Srl
37 2STADA Arzneimittel
38 1Sandoz B2B
39 1Sofgen Pharma
40 1Sun Pharmaceutical Industries Limited
41 1THEPHARMANETWORK LLC
42 4Xo Laboratory
43 1Yangtze River Pharmaceutical Group
44 1Blank
01 6CAPSULE;ORAL
02 1Coated Tablet
03 1Concentrate For Solution For Infusion
04 18Film Coated Tablet
05 1Film-Coated Tablet
06 1INJ
07 12Infusion Solution
08 2Injection
09 1Nimodipine 10Mg 50Ml 1 Units Parenteral Use
10 1Oral Solution
11 1Perfusion Solution
12 2Powder for Injection
13 5SOLUTION;ORAL
14 2Softgelatin Capsule
15 6Solution For Infusion
16 1Solution For Perfusion
17 1TAB
18 1TABLET
19 1Tablet
20 13Blank
01 2Allowed
02 5Approved
03 5Authorised
04 4Authorized
05 1Cancelled
06 4DISCN
07 6Deregistered
08 1Invalid
09 2Marketed
10 2Not Marketed
11 2Originator
12 9Prescription
13 6RX
14 2Suspended
15 1Withdrawn
16 25Blank
01 2Brainal
02 1Iskidrop
03 8NIMODIPINE
04 2NIMOTOP
05 2NYMALIZE
06 2Nemotan®
07 1Nimobrain
08 1Nimodipin "Paranova"
09 4Nimodipine
10 1Nimodipine Altan
11 1Nimodipine Labesfal
12 1Nimodipine Remontal
13 1Nimodipino Stada
14 1Nimodipino Stadafarma
15 35Nimotop
16 1Nimotop 02 Mg/Ml
17 1Nimotop Iv 50Ml
18 1Nimotop Tabs 30Mg 100S
19 1Nimovaso sol
20 2Periplum
21 1Sobrepina
22 7Blank
01 1Canada
02 3China
03 6Denmark
04 2Estonia
05 4India
06 14Italy
07 7Malta
08 2Moldova
09 4Norway
10 2South Africa
11 7Spain
12 11Sweden
13 2Switzerland
14 11USA
15 1Vietnam
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : NIMODIPINE
Dosage Form : SOLUTION;ORAL
Dosage Strength : 6MG/ML
Packaging :
Approval Date : 2025-01-22
Application Number : 213409
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NIMODIPINE
Dosage Form : SOLUTION;ORAL
Dosage Strength : 60MG/10ML
Packaging :
Approval Date :
Application Number : 213409
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NIMODIPINE
Dosage Form : SOLUTION;ORAL
Dosage Strength : 3MG/ML
Packaging :
Approval Date : 2024-07-09
Application Number : 216937
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NIMODIPINE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2007-05-02
Application Number : 77811
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NYMALIZE
Dosage Form : SOLUTION;ORAL
Dosage Strength : 3MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2013-05-10
Application Number : 203340
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NYMALIZE
Dosage Form : SOLUTION;ORAL
Dosage Strength : 6MG/ML
Packaging :
Approval Date : 2020-04-08
Application Number : 203340
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NIMOTOP
Dosage Form : CAPSULE;ORAL
Dosage Strength : 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1988-12-28
Application Number : 18869
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Nimotop
Dosage Form :
Dosage Strength : 36 Bust Grat 30 Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Nimotop
Dosage Form :
Dosage Strength : 36 Cpr Riv 30 Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : RX
Registration Country : USA
Brand Name : NIMODIPINE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2008-01-17
Application Number : 76740
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Nimodipine
Dosage Form :
Dosage Strength : Gtt Os 25 Ml 30 Mg/0.75 Ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Periplum
Dosage Form :
Dosage Strength : 36 Cpr Riv 30 Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NIMODIPINE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2015-07-24
Application Number : 201832
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NIMODIPINE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2007-04-17
Application Number : 77067
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NIMODIPINE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2014-04-07
Application Number : 90103
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Nimotop
Dosage Form :
Dosage Strength : 36 Cpr Riv 30 Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Nimotop
Dosage Form :
Dosage Strength : 36 Cpr Riv 30 Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Nimodipine
Dosage Form :
Dosage Strength : Gtt Os 25 Ml 30 Mg/0.75 Ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Nimodipine
Dosage Form :
Dosage Strength : Gtt Os 25 Ml 30 Mg/0.75 Ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
